Lifespan Vision Ventures

← Back to your selection

Activity in this selectionEnterprise software

Rounds participated in: 2
Confirmed lead rounds: —
New companies: 2
Funding in participating rounds: $13.7M

By stage

Pre-seed1

Series A1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection

Aug 10

Remedium Bio

Develops durable protein therapeutics via gene therapy for chronic diseases

$10MSeries A

Role not disclosed

Feb 18

Sift Biosciences

Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases

$3.7MPre-Seed

Role not disclosed